ClinicalThought

Share

Program Content

Activities

  • Oral SERDs in Breast Cancer
    A Focus on Oral SERDs in Patients With HR+/HER2- Breast Cancer: Avoiding Early Discontinuation
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 27, 2024

    Expires: March 26, 2025

Faculty

cover img faculity

Marla Lipsyc-Sharf, MD

Health Sciences Clinical Instructor of Medicine
Division of Hematology/Oncology
UCLA David Geffen School of Medicine
Los Angeles, California

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from Lilly.

Lilly

Partners

Practicing Clinicians Exchange

ProCE Banner

ProCE, LLC

ProCE Banner